Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 7,477-7,488 of 10,592
Device study icon
Active Not RecruitingNCT05887713

Novel Mental Health Therapies to Improve Military Readiness

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In United States
AnxietyDeviceA study involving a tool, app, wearable, test, or medical device.Over 18 Years
Countries
United States
Sponsor
David Moss
Condition
Anxiety
Drug study icon
CompletedNCT04831684

Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugA study involving a medication or substance.From 21 Years to 40 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
CompletedNCT04011280

Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness

This study exists to see whether smoking support or smoking-related treatment is workable and worth testing more broadly. Researchers are trying to understand whether smoking support or smoking-related treatment can give earlier or clearer feedback during care.

In United States
Schizophrenia, Addiction, ...DrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Schizophrenia, Addiction, ...
Drug study icon
CompletedNCT02230384

Novel Smoking Cessation Drug for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 66 Years
Countries
United States
Sponsor
K.N. Roy Chengappa
Condition
Schizophrenia
Device study icon
Enrolling By InvitationNCT07369180

NQ Square TMS for MDD 1Dx3S Adults Multi-site Sham-controlled Protocol

This study is comparing Active Accelerated rTMS Treatment with Sham Accelerated Protocol for people with depression. Participants receive Active Accelerated rTMS Treatment or Sham Accelerated Protocol and complete study visits and assessments.

In United States
DepressionDeviceFrom 22 Years to 85 Years
Countries
United States
Sponsor
NeuroQore Inc.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.